Extrinsic compression of pancreactic duct by intragastric balloon treatment and its potential to cause acute pancreatitis: two case C reports and clinical discussion

被引：2

作者：

Halpern, Bruno ^{[1
]}

Sorbello, Mauricio Paulin ^{[2
]}

Libanori, Hilton Telles ^{[3
]}

Mancini, Marcio Correa ^{[1
,2
,3
]}

机构：

[1] Univ Sao Paulo, Dept Endocrinol, Obes & Metab Syndrome Unit, Hosp Clin, Sao Paulo, Brazil

[2] Univ Sao Paulo, Dept Gastroenterol, Hosp Clin, Sao Paulo, Brazil

[3] Hosp Albert Einstein, Div Gastrintestinal Surg, Sao Paulo, Brazil

来源：

OBESITY RESEARCH & CLINICAL PRACTICE | 2020年 / 14卷 / 02期

关键词：

Intragastric balloon; Acute pancreatitis; Obesity treatment; Lipase; Amylase; Liraglutide; LIRAGLUTIDE;

D O I：

10.1016/j.orcp.2020.02.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We describe two cases of increased pancreatic enzyme levels after intragastric balloon (IGB) placement possibly related to extrinsic pancreatic duct compression, followed by a short review of the literature. Case 1 is the first, to our knowledge, of a patient with asymptomatic increase of pancreatic enzymes due to pancreatic duct compression, with unknown clinical significance. We hypothesize that this finding maybe can be relatively common in IGB users and almost certainly an important risk factor for the development of acute pancreatitis (AP). On the other hand, case 2 reports an AP that occurred one day after IGB placement, presented with nausea and vomiting, making AP a differential diagnosis of initial IGB intolerance. (C) 2020 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

引用

页码：191 / 193

页数：3